The latest information

Well-equipped and integrated R&D labs for custom bioprocess development from concept to scalable production

Factories of the future - a far dream or close reality?

David Nauwelaers strengthens the development of Antleron’s manufacturing capabilities enabling custom bioprocess scaling and GMP translation

Britt Van Ballaer develops bioreactor systems in support of scalable bioprocesses and next generation therapies

Digital twins fast-track bioprocess development

Bayesian optimization accelerates cell therapy process development

Our Antleron Fellows: a vibrant, multidisciplinary team of scientists

Antleron and Tuatara Dx team up to revolutionize point-of-need diagnostics

Trends Gazellen 2024 nomination for Antleron

Antleron joins Flemish-Brabant advanced therapy delegation to Heidelberg-Mannheim ecosystem

Antleron interns taking part in innovative ATMP developments

Showcasing our collaborative Biodevice-CRO offering at Knowledge for Growth 2023 in Antwerp

Dieter Hauwaerts brings strategic and operational ATMP excellence to the Antleron team

Antleron ranked No 8 among the fastest growing, small enterprises in Flemish-Brabant

Synergy of Process Analytical Technology and QbD enables next-generation bioprocesses

The antler story

Bioreactors - Satisfying global cell manufacturing needs

Additive Manufacturing – Enabling custom bioprocess solutions

ATMP Blog Series : Adventurous road towards realizing advanced therapies' unprecedented opportunities